Pancreatic ductal adenocarcinomas (PDAC) are one of the main cause of cancer-related deaths, mainly due to the lack of therapeutic options. Thus, research on early detection with suitable diagnostic procedures, further broadening operation techniques, and determining whether chemotherapy or radiation therapy is the most effective perioperative treatment is needed for treatment of PDAC . Surgery is the primary mode of treatment for pancreatic cancer.
Only 15%-25% of patients founds eligible with resectable disease at primary diagnosis but, an important role exists for chemotherapy and/or radiation therapy in the treatment of patients with resectable disease. Guidelines from the National Comprehensive Cancer Network (NCCN) recommend that decisions about resectability involve input from a multidisciplinary group of specialists at a high-volume center. The NCCN panel also agreed that…
